DE | EN
Diese Veranstaltung hat bereits stattgefunden.
Folgende kommende Veranstaltungen könnten Sie interessieren:
21.01.2019 Orbital, Lacrimal and Ophthalmic-Plastic Surgery
20.02.2019 5th ITEDS Thyroid Eye Disease Symposium
25.02.2019 Medical Retina
02.03.2019 7th Uveitis Course Venice IUSG|ICO
07.03.2019 4th Global Pediatric Ophthalmology Congress

Inflammatio 2018

64432 Tel Aviv-Yafo, Israel

Inflammatio 2018

2nd International Colloquium on Intraocular Inflammation

Datum:
26.11.2018, 17:30 - 29.11.2018, 14:30
Veranstalter:
International Uveitis Study Group (IUSG)
Kurzbeschreibung:
Inflammatio 2018 that will take place in Tel Aviv, Israel from the 27th to the 29th of November.The idea of inflammatio is to have a high standard forum for discussing challenging uveitis topics. The program will include important aspects in diagnostics, surgery and treatment. We would like to invite you to participate actively in the meeting, since the core of the meeting is aimed to have lots of discussions. Your active participation is no doubt critical for the success of the meeting.
Fortbildungspunkte: 

alle

Max. Teilnehmer: unbegrenzt
Gebühren ab: 170,00 USD

Hinweis:
On-Site Registration:

1 day participation: $ 170
3 day participation: $ 450
Bemerkungen:
Diese Veranstaltung findet einmalig statt und bietet Fortbildungsmöglichkeiten für alle.
Veranstaltungsnummer: 27913
Gebühren ab:
ab 170,00
verfügbare Plätze: unbegrenzt
Sprache: Englisch
 
Vom Veranstalter gemeldetes Programm:
MON, 26 November 2018    
     
17:30 - 19:00 Welcome reception in the Dan Hotel  
     
TUE, 27 November 2018    
     
08:15 - 09:00 Registration  
09:00 - 09:05 Opening  
     
  Experimental Uveitis Models in 2018  
     
09:05 - 09:25 Regulation of Th17 response by IL-17:
implications for autoimmunity 
Rachel Caspi
09:25 - 09:45 Lessons from experimental rat models for
chronic and relapsing autoimmune uveitis
Gerhild Wildner
09:45 - 10:05 Of mice and men and women James Rosenbaum
10:05 - 10:20 Discussion  
     
  The Role of Microbiome in Uveitis  
     
10:45 - 11:00 Welcome to the World of Microbiota Nida Sen
11:00 - 11:18 Microbiome and the Eye-the good and the bad Rachel Caspi
11:18 - 11:38 Microbiome and Tuberculosis Florian Hoelzl​
11:38 - 11:56 Microbiome and HLA-B27 James Rosenbaum
11:56 - 12:16 Virome and the Eye Jolanda D.F de Groot-Mijnes
12:16 - 12:30 Discussion  
     
  Multimodal Imaging (MMI) for Inflammatory Outer Retinopathies  
     
13:30 - 13:42 What have we learned from MMI about
inflammatory outer retinopathies
Michal Kramer
13:42 - 13:54 Insights to outer retinopathies from OCTA and Adaptive Optics Padmamalini Mahendradas
13:54 - 14:04 Clues for inflammation by MMI of rarest entities Orly Gal-Or
14:04 - 14:16 Clinical application of Artificial Intelligence and Machine Learning Noam Bresiz
14:16 - 14:26 The way to use Artificial Intelligence and
machine learning in Uveitis Diagnosis
 Antoine Brezin
14:26 - 14:36 How MMI changes our management of
inflammatory outer retinopathies
Padmamalini Mahendradas
14:36 - 14:45 Discussion  
     
15:15 - 16:15 Controversies  
     
  1. Systemic vs intraocular steroid therapy
for acute toxoplasmic retinochoroiditis 
pro systemic: Emmett Cunningham
pro intraocular: Rubens Belfort
  2. Biologics vs immunosuppressives as
first line treatment for JIA-induced uveitis
pro Biologics: Athimalaipet V. Ramanan
pro Immunosuppressives: Debra Goldstein
  3. Treatment of Behcet´s Disease: anti-TNF vs interferon alpha pro: anti-TNF-alpha: Shiri Shulman
pro: interferon alpha: Manfred Zierhut
     
  Progression Markers  
     
16:15 - 16:25 Progression markers of Vogt Koyanagi Haradas Disease Nobuyoshi Kitaichi 
16:25 - 16:35 Biomarkers for increased risk of developing uveitis in JIA Joke de Boer
16:35 - 16:45 Laser flare photometry can predict a recurrence in Behçet-uveitis Nilüfer Yalcindag
16:45 - 17:00 Discussion  
     
WED, 28 November 2018    
     
08:30 - 09:00 Registration (new participants)  
     
  Tuberculosis - From Infection to Inflammation  
     
09:00 - 09:12 Immunology of general TB infection  Florian Hoelzl​
09:12 - 09:24 Immunology of ocular TB infection  Soumyava Basu
09:24 - 09:36 Update of the the COTS-studies Reema Bansal
09:36 - 09:48 Clinical spectrum of “inflammatory” TB  Vasconcellos-Santos D​aniel
09:48 - 10:00 Quantiferon testing in endemic vs. non-endemic areas Soon Phaik Chee
10:00 - 10:15 Discussion  
     
  Preparing for Intraocular Surgery in Uveitis Patients  
     
10:45 - 11:00 General principles of medical preparation for
intraocular surgery in uveitis
 
11:00 - 11:15 Intra- and perioperative care during cataract surgery  
11:15 - 11:30 Preparing for glaucoma drainage and vitrectomy in uveitis  
11:30 - 12:30 Round Table  Moderator: Nicholas Jones Cristina Muccioli,
Nisha Acharya, Matthias Becker
     
  Uveitis Related Macular Edema  
     
13:30 -13:50 Differences between Uveitis macular edema and other etiologies Francine Behar Cohen 
13:50 - 14:00 Role of Cytokines in uveitis related CME  Marina Mesquida
14:00 - 14:15 Macular edema-what have the MUST trials taught us Sue Lightman
14:15 - 14:30  Options for treatment of uveitis related CME Marina Mesquida
14:30 - 14:40 Biologics and uveitic CME Oren Tomkins
14:40 - 15:00 Discussion  
     
  Future Protocols for Uveitis Trials  
     
15:30 - 15:35 Introduction Philip Murray
15:35 - 15:50 The Problem of outcome measurements in uveitis trials Nisha Acharya
15:50 - 06:03 Clinical trials in uveitis-The Industry Perspective Ron Neuman
16:03 - 16:16 Clinical trials in uveitis-The Reading Center Perspective Marion Munk 
16:16 - 16:29 Why previous uveitis trials often failed James Rosenbaum
16:29 - 17:00 Round Table: What would be your ideal uveitis trial Moderator: Philip Murray
     
THU, 29. November 2018    
     
08:30 - 09:00 Registration (new participants)  
     
  Biologic Agents for Uveitis  
     
09:00 - 09:12 Definition of “Failure” under biologic drugs  Debra Goldstein
09:12 - 09:24 Biologics inducing uveitis Manfred Zierhut
09:24 - 09:36 Side effects of biologics and biosimilars  Martin van Hagen
09:36 - 09:48 Off label biologics as the next step Eric Suhler
09:48 - 10:15 Discussion  
     
10:45 - 12:00 Case Reports Chairs: Careen Lowder, Massimo Accorinti,
Zohar Habot-Wilner
    Mystery Cases - Israeli Uveitis Group
     
12:00 - 12:30 Presentation of the best 5 Posters  
     
  Uveitis in Immune Incompetent Patients  
     
13:30 - 13:42 AIDS associated Uveitis in 2018  Jyotirmay Biswas
13:42 - 13:54 Role of CMV in immune incompetence  Alejandra dela Torre
13:54 - 14:06 Post-Transplantation-Lymphoproliferative disorders Manfred Zierhut
14:06 - 14:18 Immune mediated ocular toxicity following the use
of Immune Checkpoint Inhibitors for malignancy
Nida Sen
14:18 - 14:30 Carcinoma-associated Uveitis Radgonde Amer
Veranstaltungsort:
Dan Tel Aviv Hotel
Anschrift:
HaYarkon St 99
64432 Tel Aviv-Yafo, Israel
Veranstalter:
International Uveitis Study Group (IUSG)
Organisation:

International Uveitis Study Group (IUSG)

 
Hinweis:

 

Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter.




Tour to Jerusalem:

Sunday, November 25th.
Meeting Point&Time : 8AM leaves Dan Tel Aviv Hotel
Tour includes: an English speaking guide, transportation from the Dan Tel Aviv Hotel, light meal + beverage.
Price: $100 per person. Price based on participation of 15 people and may change according to the number of participants.
Entry fees may be required.

Monday 26/11 : 17.30-19.00 Welcome reception at the Dan hotel

Tuesday 27/11 : 17.00 -19.00 Meeting cocktail at the Dan hotel

 

Tel Aviv Walking Tour:

Friday, November 30th
Meeting Point&Time : 9AM , Dan Tel-Aviv Hotel
Tour includes: an English speaking guide
Price : $55 per person. Price based on participation of 10 people and may change according to the number of participants.
Entry fees may be required.